L Leifeld

Author PubWeight™ 17.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000 1.49
2 Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 1999 1.33
3 Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006 1.17
4 T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions. J Acquir Immune Defic Syndr 2000 1.00
5 Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J Immunol Methods 2000 0.92
6 Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy 2008 0.91
7 Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis 1997 0.90
8 Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006 0.90
9 Intrahepatic mRNA levels of interferon gamma and tumor necrosis factor alpha and response to antiviral treatment of chronic hepatitis C. J Hum Virol 2001 0.86
10 Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment. J Immunol Methods 1999 0.85
11 [S2k guidelines diverticular disease/diverticulitis]. Z Gastroenterol 2014 0.85
12 Intrahepatic expression of interleukin-1beta and tumor necrosis factor-alpha in chronic hepatitis C. J Infect Dis 1999 0.82
13 Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol 1997 0.81
14 Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C. Digestion 2000 0.78
15 Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis. J Crohns Colitis 2012 0.78
16 Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C. Z Gastroenterol 1999 0.78
17 Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial. Liver 2000 0.77
18 T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro. J Neuroimmunol 1994 0.76
19 Successful non-invasive treatment of stricturing fibrosing colonopathy in an adult patient. Eur J Med Res 2011 0.75
20 [56-year-old man with acrocyanosis, livedo reticularis, renal failure and arterial hypertension. Cholesterol embolism syndrome (CES)]. Internist (Berl) 1998 0.75
21 [Prevention and conservative therapy of diverticular disease]. Chirurg 2014 0.75
22 [Hepatic pseudolesion caused by puncture]. Aktuelle Radiol 1997 0.75
23 Conservative management. Dig Dis 2012 0.75
24 [Diverticulitis should be treated conservatively]. Dtsch Med Wochenschr 2008 0.75